INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹437 Cr | ₹332 Cr | ₹288 Cr | ₹265 Cr | ₹213 Cr |
What is the latest Sundry Debtors ratio of INNOVA CAPTAB ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹437 Cr |
| Mar2025 | ₹332 Cr |
| Mar2024 | ₹288 Cr |
| Mar2023 | ₹265 Cr |
| Mar2022 | ₹213 Cr |
How is Sundry Debtors of INNOVA CAPTAB Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹437 Cr | 31.85 | |
| Mar2025 | ₹332 Cr | 14.96 | |
| Mar2024 | ₹288 Cr | 8.77 | |
| Mar2023 | ₹265 Cr | 24.70 | |
| Mar2022 | ₹213 Cr | - | |
Compare Sundry Debtors of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹6,753.9 Cr | 3.1% | 14% | 34% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,398.0 Cr | -0.4% | -3.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹248,664.0 Cr | 0.4% | 9.9% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,738.0 Cr | -3.4% | -4.2% | 37.1% | Stock Analytics | |
| CIPLA | ₹110,794.0 Cr | 0.5% | -3.2% | -12.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,749.4 Cr | 0.9% | 0% | -11% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | 3.1% |
14% |
34% |
| SENSEX | -0.8% |
-3.8% |
-8.9% |
You may also like the below Video Courses